个人信息
Personal Information
联系方式
Contact Information
个人简介
Personal Profile
Sep 2017 – Jun 2020Ph.D.Social Medicine and health Management, Peking University, Beijing, China
Sep 2018 – Sep 2019Joint Ph.D.Social and behavior science, Harvard University, Boston, America
Sep 2014 – Jun 2017MMedSciSocial Medicine and health Management, Peking University, Beijing, China
Sep 2009 – Jun 2014BMedSciHealth Service Management, Anhui Medical University, Hefei, Anhui, China
徐婷婷，副教授，公共卫生学院卫生政策系。长期从事健康经济与政策，健康经济与行为研究。负责国家级或省部级课题5项，发表学术论文30余篇，参编卫生经济学专业教材多部。
卫生经济教研室，团队成员有韩优莉、高广颖、吴妮娜、徐婷婷
2023.01-2025.12 PI The Disparities and Intervention Mechanism of Preconception CareUtilization under the Theoretical Framework of Opportunity Inequality. 300,000 CNY
2022.01-2024.12 PI Health economic evaluation of diagnosis of coronary heart disease based on decision tree modelBeijing municipal education commission. 50,000 CNY
2021.01-2023.12 PI Quantification of health risks in sub-health population in ChinaTaikang Insurance Group Co., Ltd.600,000 CNY
2021.03-2022.03 PI Health economic evaluation of 3D surgery modelHualangte Science and Technology Co., Ltd150,000 CNY
2020.10-2121.12 PI Health economic evaluation of functional diagnosis of coronary heart disease CuraCloud Technology Co., Ltd 300,000 CNY
2021.07-2023.12 CI Health economics evaluation of coronary flow reserve score calculation software Beijing Municipal Science &TechnologyCommission 600,000 CNY
2022.01-2025.12 PI The Disparities and Intervention Mechanism of Preconception Care Utilization under the Theoretical Framework of Opportunity InequalityNational Nature Science Foundation of China 300,000 CNY
2022.01-2024.12 PI Health economic evaluation of diagnosis of coronary heart disease based on decision tree modelBeijing municipal education commission50,000 CNY
2021.01-2023.12 PI Quantification of health risks in sub-health population in ChinaTaikang Insurance Group Co., Ltd.600,000 CNY
2021.03-2022.03 PI Health economic evaluation of 3D surgery modelHualangte Science and Technology Co., Ltd150,000 CNY
2020.10-2121.12PIHealth economic evaluation of functional diagnosis of coronary heart diseaseCuraCloud Technology Co., Ltd300,000 CNY
2021.07-2023.12CIHealth economics evaluation of coronary flow reserve score calculation softwareBeijing Municipal Science &TechnologyCommission600,000 CNY
1. Xu T, Xia Q, Lai X, He K, Fan D, Ma L, Fang H. Subsidized gestational diabetes mellitus screening and management program in rural China: a pragmatic multicenter, randomized controlled trial. BMC Med. 2024 Mar 5;22(1):98. doi: 10.1186/s12916-024-03330-1.
2. Wu X, Tiemeier H, Xu T. Trends in gestational diabetes prevalence in China from 1990 to 2024: a systematic review and meta-analysis. Rev Endocr Metab Disord. Published online July 15, 2025. doi:10.1007/s11154-025-09987-0
3. Xu T, Faleschini S, Rifas-Shiman SL, et al. Maternal glucosetolerance in pregnancy and child cognitive and behavioural problems in earlyand mid-childhood. Paediatr Perinat Epidemiol. 2021;35(1):109-119.
4. Xu T, Lai X, He K, Ma L, Fang H. Subsidy programme forgestational diabetes mellitus screening and lifestyle management in rural areasof western China: a study protocol for a multicentre randomised controlledtrial. BMJ Open. 2021;11(7):e045503.
5. Xu T, He Y, Dainelli L, et al. Healthcare interventions for theprevention and control of gestational diabetes mellitus in China: a scopingreview. BMC Pregnancy Childbirth. 2017;17(1):171.
6. Xu T, Dainelli L, Yu K, et al. The short-term health andeconomic burden of gestational diabetes mellitus in China: a modelling study.BMJ Open. 2017;7(12):e018893.
文件上传中...
